Related Experiment Video
Updated: Jun 12, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Algorithm-Driven Initiation and Adaptation of Hybrid Closed-Loop in Young Children with Type 1 Diabetes: A Pilot
Jacopo Pavan1, Erin Cobry2, Zachariah W Reed3
1Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
Algorithm-driven initiation and adjustment of automated insulin delivery (AID) systems proved safe and effective for young children (2-6 years) with type 1 diabetes. This approach improved glucose control, reducing high blood glucose levels without increasing hypoglycemia risks.
Area of Science:
- Pediatric Endocrinology
- Biomedical Engineering
- Diabetes Technology
Background:
- Glucose regulation in young children presents unique challenges due to variability and behavioral factors.
- Automated insulin delivery (AID) benefits are known, but initiation and adjustment are complex for healthcare providers.
- Current methods require expert adjustments, highlighting a need for more accessible solutions.
Purpose of the Study:
- To investigate the safety and efficacy of algorithm-driven initiation and parameter adjustments for AID in children aged 2-6 years.
- To evaluate if an investigational software can safely manage AID settings in this pediatric population.
- To compare algorithm-driven AID management against baseline and expert-managed systems.
Main Methods:
- A pilot study involving 32 children (aged 2-6 years) using AID at home for 8 weeks.
- Initial settings and adjustments were provided via cloud-based investigational software, with physician oversight.
- Primary endpoints assessed time spent below 54 mg/dL and above 250 mg/dL, with efficacy measured by time in range (70-180 mg/dL) and mean glucose.
Main Results:
- AID with algorithm-driven settings was noninferior for safety endpoints (time <54 mg/dL and >250 mg/dL) compared to baseline (P < 0.001).
- Significant improvements were observed in time in range (70-180 mg/dL) (P = 0.005) and reduced time >250 mg/dL (P = 0.003).
- No significant difference was found in time <70 mg/dL (P = 0.34) or compared to expert-managed AID.
Conclusions:
- Algorithm-driven initiation and adjustment of AID systems are safe and effective for young children with type 1 diabetes.
- This technology offers a promising approach to simplify AID management in pediatric care.
- Further validation in larger cohorts is warranted to confirm these findings.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction

